Clinical Trial
doi: 10.1159/000417894.
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO
Affiliations
- PMID: 2684520
- DOI: 10.1159/000417894
Item in Clipboard
Clinical Trial
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO
Contrib Nephrol.
1989.
No abstract available
Similar articles
-
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study.Contrib Nephrol. 1989;76:201-11; discussion 212-8. doi: 10.1159/000417896. Contrib Nephrol. 1989. PMID: 2684523 Clinical Trial. No abstract available.
-
Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.Contrib Nephrol. 1989;76:166-78; discussion 212-8. Contrib Nephrol. 1989. PMID: 2684519 Clinical Trial. No abstract available.
-
Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease.Contrib Nephrol. 1989;76:227-40; discussion 240-1. doi: 10.1159/000417899. Contrib Nephrol. 1989. PMID: 2684524 Clinical Trial. No abstract available.
-
[Review of the scientific evidence of the efficiency of erythropoietin use].Med Clin (Barc). 2006 Sep 23;127(11):415-20. doi: 10.1157/13092767. Med Clin (Barc). 2006. PMID: 17020686 Review. Spanish. No abstract available.
-
Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.Przegl Lek. 1992;49(1-2):41-2. Przegl Lek. 1992. PMID: 1455005 Review. No abstract available.
Cited by
-
Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.Drugs. 1989 Dec;38(6):863-99. doi: 10.2165/00003495-198938060-00004. Drugs. 1989. PMID: 2693045 Review.
-
Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.Cochrane Database Syst Rev. 2015 Dec 16;2015(12):CD011122. doi: 10.1002/14651858.CD011122.pub2. Cochrane Database Syst Rev. 2015. PMID: 26671531 Free PMC article.
-
Erythropoietin: physiology and molecular mechanisms.Heart Fail Rev. 2008 Dec;13(4):405-14. doi: 10.1007/s10741-008-9083-0. Epub 2008 Jan 31. Heart Fail Rev. 2008. PMID: 18236154 Review.
-
The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.Pediatr Nephrol. 1992 Nov;6(6):536-41. doi: 10.1007/BF00866497. Pediatr Nephrol. 1992. PMID: 1482641
-
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3. Cochrane Database Syst Rev. 2023. PMID: 36791280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
